大胆管结石的内镜治疗:系统综述与网状Meta分析
结果显示,除机械碎石外,各疗法均显著优于内镜乳头括约肌切开术;单人操作胆道镜提升结石清除率最优,尤其在>15 mm结石中,S+EPLBD为可行替代。各疗法不良事件率无显著差异。
要点
- 大胆管结石(>10 mm)内镜治疗中,胆道镜结石清除成功率排名最高(SUCRA 0.99)。
- 结石>15 mm时,胆道镜与S+EPLBD优于其他方式(SUCRA 0.97与0.71)。
- 各内镜治疗间不良事件率无显著差异,术后胰腺炎和出血最常见。
核心结论
- 在大胆管结石患者中,胆道镜是最有效的取石方法,尤其适用于结石>15 mm者。
- S+EPLBD可作为成本更低、可及性更高的替代方案。
研究设计与样本
- 比较内镜乳头括约肌切开术、球囊括约肌成形术、S+EPLBD、机械碎石和单人操作胆道镜等治疗方式。
- 采用GRADE标准评价证据质量。
主要发现
- 除机械碎石外,所有治疗在结石清除率上均显著优于括约肌切开术(RR 1.03–1.29)。
- 胆道镜优于球囊括约肌成形术(RR 1.24;95%CI 1.07–1.45)、S+EPLBD(RR 1.23;95%CI 1.06–1.42)和机械碎石(RR 1.34;95%CI 1.14–1.58)。
- 结石清除成功率SUCRA评分:胆道镜0.99,S+EPLBD 0.68。
- 仅纳入>15 mm结石的研究时,胆道镜与S+EPLBD的SUCRA评分分别为0.97和0.71。
- 各干预措施与括约肌切开术或其他治疗相比,不良事件率均无显著差异;术后ERCP胰腺炎和出血最常见。
临床怎么用
- 对于大胆管结石(尤其>15 mm),可优先考虑胆道镜取石以提高清除成功率。
- 在资源有限或胆道镜不可及时,S+EPLBD可作为有效替代方案。
- 选择术式时需综合结石大小、设备可及性和成本等因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Several endoscopic methods have been proposed for the treatment of large biliary stones. We assessed the comparative efficacy of these treatments through a network meta-analysis. METHODS: Nineteen randomized controlled trials (2752 patients) comparing different treatments for management of large bile stones (>10 mm) (endoscopic sphincterotomy, balloon sphincteroplasty, sphincterotomy followed by endoscopic papillary large balloon dilation [S+EPLBD], mechanical lithotripsy, single-operator cholangioscopy [SOC]) with each other were identified. Study outcomes were the success rate of stone removal and the incidence of adverse events. We performed pairwise and network meta-analysis for all treatments, and used Grading of Recommendations, Assessment, Development, and Evaluation criteria to appraise the quality of evidence. RESULTS: All treatments except mechanical lithotripsy significantly outperformed sphincterotomy in terms of stone removal rate (risk ratio [RR], 1.03-1.29). SOC was superior to other adjunctive interventions (vs balloon sphincteroplasty [RR, 1.24; 95% CIs, 1.07-1.45], vs S+EPLBD [RR, 1.23; range, 1.06-1.42] and vs mechanical lithotripsy [RR, 1.34; range, 1.14-1.58]). Cholangioscopy ranked the highest in increasing the success rate of stone removal (surface under the cumulative ranking [SUCRA] score, 0.99) followed by S+EPLBD (SUCRA score, 0.68). SOC and S+EPLBD outperformed the other modalities when only studies reporting on stones greater than 15 mm were taken into consideration (SUCRA scores, 0.97 and 0.71, respectively). None of the assessed interventions was significantly different in terms of adverse event rate compared with endoscopic sphincterotomy or with other treatments. Post-ERCP pancreatitis and bleeding were the most frequent adverse events. CONCLUSIONS: Among patients with large bile stones, cholangioscopy represents the most effective method, in particular in patients with larger (>15 mm) stones, whereas S+EPLBD could represent a less expensive and more widely available alternative.
引用
- Facciorusso A, Gkolfakis P, Ramai D, et al. Endoscopic Treatment of Large Bile Duct Stones: A Systematic Review and Network Meta-Analysis. Clin Gastroenterol Hepatol. 2021. PMID: 34666153. doi:10.1016/j.cgh.2021.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。